Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: Eight years single institution experience

Diseases of the Esophagus

Volumn 23, Issue 3, 2010, Pages 201-207

  Chen, M J ^a   Lee, Y C ^a,b   Chiu, H M ^a   Wu, M S ^a   Wang, H P ^a   Lin, J T ^a,c  

^a School of Medicine   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

Author keywords

Barrett's esophagus; Endoscopy; Gastroesophageal Reflux disease; Time trend

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CHINESE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SCREENING TEST; TIME; ADENOCARCINOMA; AGED; ASIAN; CHINA; COHORT ANALYSIS; ENDOSCOPY; ESOPHAGUS TUMOR; ETHNOLOGY; INCIDENCE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

ADENOCARCINOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BARRETT ESOPHAGUS; CHINA; COHORT STUDIES; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77956309590     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01012.x     Document Type: Article

References (46)

1. Goh K L. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 2007; 8: 179-85.
2. Xia H H, Phung N, Altiparmak E, Berry A, Matheson M, Talley N J. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci 2001; 46: 2716-23.
3. Loffeld R J, van der Putten A B. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion 2003; 68: 141-4.
4. Lim S L, Goh W T, Lee J M, Ng T P, Ho K Y. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol 2005; 20: 995-1001.
5. El-Serag H B, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-33.
6. Baron J H, Sonnenberg A. Hospital admissions and primary care attendances for nonulcer dyspepsia, reflux oesophagitis and peptic ulcer in Scotland 1981-2004. Eur J Gastroenterol Hepatol 2008; 20: 180-6.
7. El-Serag H B. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007; 5: 17-26.
8. Botterweck A A, Schouten L J, Volovics A, Dorant E, van Den Brandt P A. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-54.
9. Dulai G S, Guha S, Kahn K L, Gornbein J, Weinstein W M. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002; 122: 26-33.
10. Shaheen N J. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2005; 128: 1554-66.
11. Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005; 92: 151-9.
12. Lee Y C, Wang H P, Chiu H M et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol 2006; 21: 798-804.
13. Fock K M, Talley N J, Fass R et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008; 23: 8-22.
14. HongoM. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment Pharmacol Ther 2004; 20 (Suppl 8): 50-4.
15. Tu C H, Lee C T, Perng D S, Chang C C, Hsu C H, Lee Y C. Esophageal adenocarcinoma arising from Barrett's epithelium in Taiwan. J Formos Med Assoc 2007; 106: 664-8.
16. Tseng P H, Lee Y C, Chiu H M et al. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J Clin Gastroenterol 2008; 42: 1074-9.
17. Chang C Y, Lee Y C, Lee C T et al. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am J Gastroenterol 2009; 104: 13-20.
18. Asian Barrett's Consortium. Asian Barrett's Consortium's statement concerning its research objectives and plans. [Cited Jul 2009]. Available from URL: https://portals.dceg.cancer.gov/asianbarrett
19. Lundell L R, Dent J, Bennett J R et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
20. Laws & Regulations Bureau of National Health Insurance, Taiwan. Laws & regulations [Cited 7 Jan 2008]. Available from URL: http://www.nhi.gov.tw
21. Hetzel D J, Dent J, Reed W D et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903-12.
22. Vakil N, van Zanten S V, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20, quiz 43.
23. Lee Y C, Yen A M, Tai J J et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009; 58: 174-81.
24. Taiwan Cancer Registry, Bureau of Health Promotion, Department of health, ROC. Annual report of cancer registry, 2005. [Cited 10 Jun 2008.] Available from URL: http://crs.cph.ntu.edu.tw/main.php
25. Chu N F. Prevalence of obesity in Taiwan. Obes Rev 2005; 6: 271-4.
26. Pan W H, Lee M S, Chuang S Y, Lin Y C, Fu M L. Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obes Rev 2008; 9 (Suppl 1): 22-31.
27. Moki F, Kusano M, Mizuide M et al. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007; 26: 1069-75.
28. Chung S J, Kim D, Park M J et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a crosssectional case-control study of 7078 health check-up Koreans. Gut 2008; 57: 1360-1365.
29. de Vries D R, van Herwaarden M A, Smout A J, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol 2008; 103: 1349-54.
30. Wu J C, Mui L M, Cheung C M, Chan Y, Sung J J. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007; 132: 883-9.
31. El-Serag H B, Satia J A, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 2005; 54: 11-17.
32. Fox M, Barr C, Nolan S, Lomer M, Anggiansah A, Wong T. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol 2007; 5: 439-44.
33. Lee Y C, Lin J T, Chiu H M et al. Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging. Gastrointest Endosc 2007; 66: 230-6.
34. Lai C H, Kuo C H, Chen Y C et al. High prevalence of cagAand babA2-positive Helicobacter pylori clinical isolates in Taiwan. J Clin Microbiol 2002; 40: 3860-2.
35. Lee Y C, Lin J T, Chen T H, Wu M S. Is eradication of Helicobacter pylori the feasible way to prevent gastric cancer? New evidence and progress, but still a long way to go. J Formos Med Assoc 2008; 107: 591-9.
36. McColl K E, Watabe H, Derakhshan M H. Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2008; 57: 721-3.
37. Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl K E. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 2002; 122: 1248-57.
38. Suzuki H, Iijima K, Scobie G, Fyfe V, McColl K E. Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux. Gut 2005; 54: 1527-35.
39. Winter J W, Paterson S, Scobie G, Wirz A, Preston T, McColl K E. N-nitrosamine generation from ingested nitrate via nitric oxide in subjects with and without gastroesophageal reflux. Gastroenterology 2007; 133: 164-74.
40. Ward M H, Heineman E F, Markin R S, Weisenburger D D. Adenocarcinoma of the stomach and esophagus and drinking water and dietary sources of nitrate and nitrite. Int J Occup Environ Health 2008; 14: 193-7.
41. van Velzen A G, Sips A J, Schothorst R C, Lambers A C, Meulenbelt J. The oral bioavailability of nitrate from nitraterich vegetables in humans. Toxicol Lett 2008; 181: 177-181.
42. Kubo A, Levin T R, Block G et al. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol 2008; 167: 839-46.
43. Navarro Silvera S A, Mayne S T, Risch H et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer 2008; 123: 852-60.
44. Corley D A, Kubo A, Levin T R et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 133: 34-41, quiz 311.
45. Ogden C L C M, McDowell M A, Flegal K M. Obesity among adults in the United States - no change since 2003-2004. NCHS data brief no 1 Hyattsville, MD: National Center for Health Statistics. 2007.
46. Brown L M, Devesa S S, Chow W H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-7.